NASDAQ · Medical - Healthcare Information Services

DH (DH) Stock

$0.67 -1.38% NASDAQ: DH Healthcare

Valuation

MetricValue
Price$0.67
Market Cap$71.08M
P/E Ratio4.29
P/B Ratio0.58
P/S Ratio0.36
EPS (TTM)$-1.30
52-Week High$4.70
52-Week Low$0.63
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-75.50%
ROA-1.74%
ROCE-5.56%
Gross Margin72.54%
Operating Margin66.89%
Net Margin-71.49%
Debt/Equity1.16
Current Ratio1.64

Annual Financials (USD)

Metric20212022202320242025
Revenue$166.0M$223.0M$251.0M$252.0M$242.0M
Operating Profit$-27.0M$-44.0M$-330.0M$-711.0M$-21.0M
Net Profit$-52.0M$-7.0M$-202.0M$-413.0M$-139.0M
EPS$-0.19$-0.07$-1.79$-3.54$-1.30
Op Margin-16.4%-19.8%-131.2%-281.9%-8.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$2.1B$2.1B$1.8B$1.1B$735.0M
Total Liabilities$618.0M$641.0M$627.0M$482.0M$357.0M
Cash$387.0M$147.0M$131.0M$105.0M$164.0M
Borrowings$271.0M$276.0M$268.0M$253.0M$178.0M

Latest News

Definitive Healthcare Faces Rising Competitive Pressures, BofA Says MT Newswires · Jun 29, 2026 BofA Downgrades Definitive Healthcare to Underperform From Buy, Cuts Price Target to $0.70 From $3.50, Cites Intensifying Competitive Pressures MT Newswires · Jun 29, 2026 Restaurant365 Names Kate Hastings Chief Customer Officer as It Expands Investment in Customer Success PR Newswire · Jun 23, 2026 Innoviz Technologies Among 3 Compelling Penny Stocks To Consider Simply Wall St. · Jun 2, 2026 Definitive Healthcare advances data platform and integrations to deliver smarter healthcare insights GlobeNewswire · May 21, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$25.0M$36.0M$41.0M$58.0M$54.0M
Investing Cash Flow$-53.0M$-257.0M$-35.0M$-39.0M$137.0M
Financing Cash Flow$-243.0M$-5.0M$-5.0M$-38.0M$-68.0M
Net Cash Flow$363.0M$-241.0M$-16.0M$-26.0M$58.0M
Free Cash Flow$18.0M$27.0M$38.0M$46.0M$37.0M

Valuation & Return Ratios

MetricValue
PEG Ratio6.46
EV / EBITDA3.36
FCF Yield43.68%
Quick Ratio1.66
Interest Coverage-1.91
Return 1Y-78.97%
Return 3Y-92.88%
Return 5Y—

Ownership

Insiders Held3.72%
Institutions Held86.64%
Institutions Float Held89.98%
Institutional HolderSharesReport Date
Advent International LP62,493,6762026-03-31
Goldman Sachs Group Inc6,043,9002026-03-31
Blackrock Inc.2,985,5672026-03-31
Shaw D.E. & Co., Inc.2,099,5512026-03-31
Vanguard Capital Management LLC1,866,3292026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CABA $2.71 -2.17% -2.23 $441.88M 0.00%
EDIT $2.62 -2.24% -1.39 $256.50M 0.00%
KYTX $7.30 -2.54% -2.49 $443.81M 0.00%
NAKA $4.96 +15.89% -0.62 $86.31M 0.00%
NRC $18.30 -18.08% 36.21 $412.42M 2.98%

About DH

DH is led by CEO Kevin D. Coop, employs 782 people, headquartered in US, publicly traded since 2021.

DH stock trades at $0.67 with a market capitalization of $71.08M. The stock is valued at a price-to-earnings (P/E) ratio of 4.29, price-to-book of 0.58, price-to-sales of 0.36. Over the past 52 weeks the stock has ranged between $0.63 and $4.70, and currently trades 85.7% below its 52-week high.

On profitability, DH generates a return on equity (ROE) of -75.50%, return on capital employed of -5.56%, an operating margin of 66.89%, a net profit margin of -71.49%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides